[1]
|
Seetharamu, N., Ott, P.A. and Pavlick, A.C. (2010) Mucosal melanomas: A case-based review of the literature. The Oncologist, 15, 772-781.
doi:10.1634/theoncologist.2010-0067
|
[2]
|
Irvin Jr., W.P., Bliss, S.A., Rice, L.W., Taylor Jr., P.T. and Andersen, W.A. (1998) Malignant melanoma of the vagina and locoregional control: Radical surgery revisited. Gynecologic Oncology, 71, 476-480.
doi:10.1006/gyno.1998.5188
|
[3]
|
Bonner, J.A., Perez-Tamayo, C., Reid, G.C., Roberts, J.A. and Morley, G.W. (1988) The management of vaginal melanoma. Cancer, 62, 2066-2072.
doi:10.1002/1097-0142(19881101)62:9<2066::AID-CNCR2820620933>3.0.CO;2-D
|
[4]
|
Siozos, C., Bhat, A., Lonsdale, R., Nieto, J.J. and Crocker, S.G. (2005) Malignant melanoma of the uterine cervix. Journal of Obstetrics and Gynaecology, 25, 826-827.
doi:10.1080/01443610500338305
|
[5]
|
Hewitt P. Sequel to a case of recurrent melanosis of both groins and back: The disease reappearing in the brain, heart, pancreas, liver and other organs. Lancet, 1861, 263-264.
|
[6]
|
Gupta, R., Singh, S. and Mandal, A.K. (2005) Primary malignant melanoma of cervix—A case report. Indian Journal of Cancer, 42, 201-204.
|
[7]
|
Piura, B. (2008) Management of primary melanoma of the female urogenital tract. The Lancet Oncology, 9, 973-981. doi:10.1016/S1470-2045(08)70254-7
|
[8]
|
Deshpande, A.H. and Munshi, M.M. (2001) Primary ma- lignant melanoma of the uterine cervix: Report of a case diagnosed by cervical scrape cytology and review of the literature. Diagnostic Cytopathology, 25, 108-111.
doi:10.1002/dc.2014
|
[9]
|
Baruah, J., Roy, K.K., Kumar, S. and Kumar, L. (2009) A rare case of primary malignant melanoma of cervix. Archives of Gynecology and Obstetrics, 280, 453-456.
doi:10.1007/s00404-008-0912-0
|
[10]
|
An, J., Li, B., Wu, L., Lu, H. and Li, N. (2009) Primary malignant amelanotic melanoma of the female genital tract: Report of two cases and review of literature. Melanoma Research, 19, 267-270.
doi:10.1097/CMR.0b013e32831993de
|
[11]
|
Mousavi, A.S., Fakor, F., Nazari, Z., Ghaemmaghami, F., Hashemi, F.A. and Jamali, M. (2006) Primary malignant melanoma of the uterine cervix: Case report and review of the literature. Journal of Lower Genital Tract Disease, 10, 258-263. doi:10.1097/01.lgt.0000229564.11741.4e
|
[12]
|
Wasef, W.R., Roberts, J.K. and Dixon, G.R. (1999) Primary malignant melanoma of the cervix uteri. Journal of Obstetrics and Gynaecology, 19, 673-674.
doi:10.1080/01443619964094
|
[13]
|
Cantuaria, G., Angioli, R., Nahmias, J., Estape, R. and Penalver, M. (1999) Primarymalignant melanoma of the uterine cervix: Case report and review of the literature. Gynecologic Oncology, 75, 170-174.
doi:10.1006/gyno.1999.5491
|
[14]
|
Miner, T.J., Delgado, R., Zeisler, J., et al. (2004) Primary vaginal melanoma: A critical analysis of therapy. Annals of Surgical Oncology, 11, 34-39.
doi:10.1007/BF02524343
|
[15]
|
Clark, K.C., Butz, W.R. and Hapke, M.R. (1999) Primary malignant melanoma of the uterine cervix: Case report with world literature review. International Journal of Gynecological Pathology 18, 265-273.
doi:10.1097/00004347-199907000-00013
|
[16]
|
Curtin, J.A., Busam, K., Pinkel, D., et al. (2006) Somatic activation of KIT in distinct subtypes of melanoma. Journal of Clinical Oncology, 24, 4340-4346.
doi:10.1200/JCO.2006.06.2984
|
[17]
|
Antonescu, C.R., Busam, K.J., Francone, T.D., et al. (2007) L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. International Journal of Cancer, 121, 257-264. doi:10.1002/ijc.22681
|
[18]
|
Torres-Cabala, C.A., Wang, W.L., Trent, J., et al. (2009) Correlation between KIT expression and KIT mutation in melanoma: A study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Modern Pathology, 22, 1446-1456. doi:10.1038/modpathol.2009.116
|
[19]
|
Hodi, F.S., Friedlander, P., Corless, C.L., et al. (2008) Major response to imatinib mesylate in KIT-mutated melanoma. Journal of Clinical Oncology, 26, 2046-2051.
doi:10.1200/JCO.2007.14.0707
|
[20]
|
Lutzky, J., Bauer, J. and Bastian, B.C. (2008) Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation. Pigment Cell & Melanoma Research, 21, 492-493.
doi:10.1111/j.1755-148X.2008.00475.x
|
[21]
|
Jiang, X., Zhou, J., Yuen, N.K., et al. (2008) Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clinical Cancer Research, 14, 7726-7732.
doi:10.1158/1078-0432.CCR-08-1144
|